Please use this identifier to cite or link to this item:
|Title:||UBE3A regulates MC1R expression : a link to hypopigmentation in Angelman Syndrome||Authors:||Low, Daren.
|Keywords:||DRNTU::Science::Biological sciences::Molecular biology||Issue Date:||2011||Source:||Low, D., & Chen, K.-S. (2011). UBE3A regulates MC1R expression : a link to hypopigmentation in Angelman Syndrome. Pigment cell and melanoma research, 24(5), 944-952.||Series/Report no.:||Pigment cell and melanoma research||Abstract:||Angelman Syndrome (AS) is a neurogenetic disorder caused by the lack of functional ubiquitin-protein ligase E3A (UBE3A) that acts as an E3 ligase in the ubiquitin-proteosomal degradation pathway and/or as a transcriptional coactivator. Besides neurological deficit, hypopigmentation is another phenotype associated with AS patients currently attributed to the hemizygosity of the type II oculocutaneous albinism (OCA2) gene. Here we show that the melanocortin-1-receptor (MC1R) is down-regulated in the skin of the Ube3a((-/-)) mice. Luciferase-reporter assay shows that UBE3A is able to induce MC1R promoter activity. Using chromatin immunoprecipitation assay, Ube3a was observed to be physically associated with the Mc1r promoter. Deletion of the E box/SP1 element in the MC1R minimal promoter abolishes the ability of UBE3A to elevate MC1R promoter-luciferase reporter activity. Ube3a((-/-)) mice also show relative skin hypopigmentation. These results demonstrate that UBE3A plays a role in MC1R transcriptional regulation which can contribute to the development of hypopigmentation in AS patients.||URI:||https://hdl.handle.net/10356/94059
|ISSN:||1755-1471||DOI:||10.1111/j.1755-148X.2011.00884.x||Rights:||© 2011 John Wiley & Sons A/S.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SBS Journal Articles|
Updated on Jul 21, 2020
Updated on Mar 6, 2021
Page view(s) 5938
Updated on Jun 25, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.